Abstract
Creutzfeldt-Jakob is the most common spongiform encephalopathy in humans and the prototype of prions diseases. Astrogliosis and degeneration of the gray matter are the histological features. Typically starts with nonspecific prodromal symptoms that progressing to dementia with myoclonus and ataxia. We present two cases of women in middle age with progressive cognitive impairment, motor difficulties, language disorders and myoclonus that lead to death. EEG slow periodic triphasic waves and elevated protein tau and CSF14-3-3 support for The National Prion Disease Pathology Surveillance Center - Cleveland, all these findings define the conditions for the clinical diagnosis of prion disease. The differential diagnosis in the context of rapidly progressive dementia is broad including infections, poisoning, metabolic disorders, autoimmunity, vascular disease and neoplasms that could explain a possible underreporting in regional statistics. There is a possible risk association between disease and Medical Pathologists that although discussed could limit the study of histological specimens that are key to definitive diagnosis. Despite the public health importance of these conditions the current model of health limits the comprehensive management of patients.
References
TRIARHOU LC, JAKOB AM (1884-1931). Neuropathologist par Excellence. Eur Neurol. 2009;61:52-8.
http://www.nobelprize.org/nobel_prizes/medicine/laureates/1976/ Consultado: julio 20 de 2015.
PRUSINER SB. Prions. Proc Natl Acad Sci USA 1998;95(23):13363-83.
http://www.nobelprize.org/nobel_prizes/medicine/laureates/1997/ Consultado: julio 20 de 2015.
KRISTIANSEN M, DERIZIOTIS P, DIMCHEFF DE, ET AL. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell. 2007;26:175-88.
COLLINS SJ, LAWSON VA, MASTERS CL. Transmissible spongiform encephalopathies. Lancet 2004;363:51-61.
HEIDENHAIN A. Klinische und anatomische Untersuchungen Über eine eigenartige organische Erkrankung des Zentralnervensystems in Praesenium. Z Ges Neurol Psychiatry 1928;118:49-114.
ESPINOSA P, BENSALEM-OWEN M, FEE D. Sporadic Creutzfeldt-Jakob disease presenting as nonconvulsive status epilepticus case report and review of the literature. Clinical Neurology and Neurosurgery 2010;112:537-40.
MILANLIOGLU A, ET AL. Catatonic depression as the presenting manifestation of creutzfeldt-Jakob disease. J Neurosci Rural Pract. 2015 Jan-Mar;6(1):122.
DEARMOND SJ, PRUSINER SB. Prion protein transgenes and the neuropathology in prion diseases. Brain Pathol. 1995;5(1):77-89.
AGUZZI A, BAUMANN F, BREMER J. The prion's elusive reason for being. Annu Rev Neurosci 2008;31:439-77.
CUESTA J, RUIZ M, WARD H, CALERO M, SMITH A, ALONSO C, ET AL. Sensitivity to Biases of Case-Control Studies on Medical Procedures, Particularly Surgery and Blood Transfusion, and Risk of Creutzfeldt-Jakob Disease. Neuroepidemiology 2012;39:1-18.
VENNETI S. Prion Diseases. Clin Lab Med. 2010 Mar;30(1):293-309.
LIM T. Magnetic Resonance Imaging Findings in Bilateral Basal Ganglia Lesions. Ann Acad Med Singapore 2009;38:795-802.
STOECK K, SÁNCHEZ-JUAN P, GAWINECKA J, GREEN A, LADOGANA A, POCCHIARI M, ET AL. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 2012:135;3051-061.
MUAYQIL T, GRONSETH G, CAMICIOLI R. Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012;79:1499-506.
ZERR I, KALLENBERG K, SUMMERS DM, ROMERO C, TARATUTO A, HEINEMANN U. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009:132;2659-68.
ORRÚ C, BONGIANNI M, TONOLI G, FERRARI S, HUGHSON A, GROVEMAN B, ET AL. A Test for Creutzfeldt-Jakob Disease Using Nasal Brushings. N Engl J Med. 2014;371:519-29.
MODA F, GAMBETTI P, NOTARI S, CONCHA-MARAMBIO L, CATANIA M, PARK K, ET AL. Prions in the Urine of Patients with Variant Creutzfeldt-Jakob Disease. N Engl J Med. 2014;371:530-9.
ALCALDE-CABERO E, ALMAZÁN-ISLA J, BRANDEL JP, BREITHAUPT M, CATARINO J, COLLINS S, ET AL. Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010. Euro Surveill 2012;17(15):pii=20144.
PATERSON RW, TAKADA LT, GESCHWIND MD. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract. 2012 Sep;2(3):187-200.
GESCHWIND MD, SHU H, HAMAN A, SEJVAR JJ, MILLER BL. Rapidly progressive dementia. Ann Neurol. 2008;64(1):97-108.
PATERSON RW, TAKADA LT, GESCHWIND MD. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract. 2012 Sep;2(3):187-200.
GESCHWIND MD. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract. 2012 Sep;2(3):187-200.
https://www.invima.gov.co/images/stories/aliementos/decreto_2350_2004.pdf Consultado: febrero 14 de 2015.
http://www.ica.gov.co/getattachment/7108ded1-e068-4186-9e67-Ocd29ce708c2/3752.aspx Consultado: febrero 14 de 2015.
http://www.ins.gov.co/lineas-de-accion/Subdireccion-Vigilancia/sivigila/Protocolos%20SIVIGILA/PRO%20Creutzfeld.pdf Consultado: febrero 14 de 2015.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
